Interesting NVS clinical trial-->Erbitux + NVS's mTOR inhibitor. Rowinsky has several publications regarding mTOR. Also, as I recall WYE has a more advanced mTOR inhibitor in development.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.